Stock ODPVY ODONTOPREV S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Odontoprev S.A. OTC Markets

Equities

ODPVY

US67612A1060

Managed Healthcare

End-of-day quote OTC Markets
Other stock markets
 		5-day change 1st Jan Change
- USD -.--% Intraday chart for Odontoprev S.A. -.--% -.--%
05-08 Transcript : Odontoprev S.A., Q1 2024 Earnings Call, May 08, 2024
05-08 Odontoprev S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 8,932 7,717 6,559 4,997 6,420 6,156 - -
Enterprise Value (EV) 1 8,388 6,964 5,828 4,362 5,428 5,586 5,541 5,332
P/E ratio 31.5 x 21.4 x 17.5 x 10.8 x 12.6 x 11.8 x 11.5 x 11.3 x
Yield 2.08% 4.32% 2.85% - - 7.25% 7.68% 7.58%
Capitalization / Revenue 4.98 x 4.37 x 3.56 x 2.55 x 3 x 2.68 x 2.5 x 2.36 x
EV / Revenue 4.67 x 3.94 x 3.16 x 2.22 x 2.53 x 2.43 x 2.25 x 2.04 x
EV / EBITDA 20 x 12.8 x 10 x 7.57 x 8.38 x 7.91 x 7.25 x 6.53 x
EV / FCF 28.2 x 15.3 x 13.9 x 7 x 17 x 11 x 11.3 x 10.2 x
FCF Yield 3.55% 6.53% 7.2% 14.3% 5.88% 9.07% 8.83% 9.82%
Price to Book 8.04 x 6.42 x 5.81 x 4.21 x 4.63 x 4.15 x 3.82 x -
Nbr of stocks (in thousands) 582,411 583,441 572,573 553,346 552,496 550,641 - -
Reference price 2 15.34 13.23 11.45 9.030 11.62 11.18 11.18 11.18
Announcement Date 05/03/20 04/03/21 23/02/22 02/03/23 28/02/24 - - -
1BRL in Million2BRL
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,795 1,765 1,842 1,962 2,143 2,297 2,458 2,612
EBITDA 1 418.5 543.5 581.1 576 647.4 705.7 764.3 816.6
EBIT 1 397.5 518.7 523.3 538.9 591.6 660.3 701.6 750.6
Operating Margin 22.14% 29.38% 28.4% 27.47% 27.61% 28.74% 28.54% 28.73%
Earnings before Tax (EBT) 1 405.7 520 547.2 646.3 724.4 754 789.1 822.4
Net income 1 284.8 361.1 380.4 452.2 511.4 519 541.8 566.3
Net margin 15.86% 20.46% 20.64% 23.05% 23.87% 22.59% 22.04% 21.68%
EPS 2 0.4871 0.6181 0.6557 0.8385 0.9256 0.9467 0.9742 0.9870
Free Cash Flow 1 297.8 454.8 419.5 623.5 319.3 506.5 489.5 523.5
FCF margin 16.59% 25.76% 22.77% 31.78% 14.9% 22.05% 19.91% 20.04%
FCF Conversion (EBITDA) 71.16% 83.68% 72.2% 108.25% 49.32% 71.77% 64.05% 64.11%
FCF Conversion (Net income) 104.57% 125.94% 110.3% 137.88% 62.44% 97.59% 90.35% 92.44%
Dividend per Share 2 0.3191 0.5711 0.3265 - - 0.8110 0.8589 0.8477
Announcement Date 05/03/20 04/03/21 23/02/22 02/03/23 28/02/24 - - -
1BRL in Million2BRL
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 469.4 471.5 481 495.4 513.7 523.8 527.7 546 545.2 550.7 549.9 567.4 580.7 592.7
EBITDA 1 139.8 166.3 143.5 137.7 128.5 202 147.5 156.2 141.6 202.5 159.9 161.2 151.1 -
EBIT 1 102.7 160.6 133.1 127.8 117.4 190.5 135 133.5 124.6 188.1 127.1 137.4 149.5 204.7
Operating Margin 21.88% 34.05% 27.68% 25.8% 22.86% 36.37% 25.57% 24.46% 22.85% 34.16% 23.12% 24.22% 25.74% 34.54%
Earnings before Tax (EBT) 1 - 234.1 147.8 130.4 134 246.2 - - 164.4 223.9 165.5 161.2 149.5 -
Net income 1 87.18 161.5 99.57 96.19 94.95 169.6 117.2 123.4 114.6 155.4 116 113.3 105.5 -
Net margin 18.57% 34.24% 20.7% 19.42% 18.48% 32.39% 22.22% 22.6% 21.02% 28.22% 21.1% 19.97% 18.16% -
EPS 2 0.1517 0.3135 0.1790 0.1740 0.1720 0.3070 0.2120 0.2230 0.2074 0.2820 0.2100 0.2051 0.1909 -
Dividend per Share 2 0.0928 0.1357 - 0.0317 - - - - - - 0.2618 0.1995 0.1949 -
Announcement Date 23/02/22 27/04/22 27/07/22 26/10/22 02/03/23 11/05/23 09/08/23 09/11/23 28/02/24 07/05/24 - - - -
1BRL in Million2BRL
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 544 753 731 634 992 570 615 824
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 298 455 420 623 319 507 490 524
ROE (net income / shareholders' equity) 26.6% 31.2% 32.8% 39.3% 40.7% 38.2% 34% 34.5%
ROA (Net income/ Total Assets) 16.7% 19.6% 19.7% 22.9% 25.3% 20.8% 20.4% -
Assets 1 1,708 1,845 1,927 1,977 2,018 2,499 2,662 -
Book Value Per Share 2 1.910 2.060 1.970 2.140 2.510 2.700 2.920 -
Cash Flow per Share 0.5100 0.5200 0.8100 1.260 0.7500 - - -
Capex 1 11 35.3 52 71.4 95.3 94 93.5 93.5
Capex / Sales 0.61% 2% 2.82% 3.64% 4.45% 4.09% 3.8% 3.58%
Announcement Date 05/03/20 04/03/21 23/02/22 02/03/23 28/02/24 - - -
1BRL in Million2BRL
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Odontoprev S.A.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
9
Last Close Price
11.18 BRL
Average target price
12.56 BRL
Spread / Average Target
+12.30%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector HMO Medical Centers

1st Jan change Capi.
HAPVIDA PARTICIPAÇÕES E INVESTIMENTOS S.A. Stock Hapvida Participações e Investimentos S.A.
-15.73% 5.25B
HMO Medical Centers
  1. Stock Market
  2. Equities
  3. ODPV3 Stock
  4. ODPVY Stock
  5. Financials Odontoprev S.A.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW